Xin Tai Medical (02291) announced that its Supervisory Board has recommended the appointment of Wang Yong as Supervisor and Chairman of the second-term Supervisory Board. This nomination follows standard corporate governance procedures for board succession planning. The proposed leadership transition demonstrates the company's commitment to maintaining robust oversight structures while ensuring continuity in governance functions. Wang Yong's expected dual role as both Supervisor and Chairman would consolidate board leadership responsibilities under a single executive.